Adjuvant Effects on Morphine-Induced Suppression of Immune Responses to MN rgp120/HIV-1 in Mice

  • Peter A. Virsik
  • Jeanine L. Bussiere
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 373)


Intravenous drug users (IDUs) are more susceptible to infections, including HIV-1 (1Haverkos and Lange, 1990), and have been shown to have suppressed immune responses (Brown et al., 1974). This may be due to a combination of effects, including immunosuppressive effects of the drugs themselves (i.e., morphine, heroin, cocaine), poor nutrition and sharing contaminated needles. Given that a very high percentage of heroin users report injection, often with shared equipment, as the primary route of administration, this population is at high risk for becoming infected with HIV-1. We have shown previously that morphine decreases primary and secondary antibody responses both in vitro and in vivo (Bussiere et al.,1993b) in a murine model. This model may provide information on one risk factor; the interaction between the drugs of abuse and immune responses to a subunit vaccine, recombinant glycoprotein 120 from the MN strain of HIV-1 (rgp120). In addition, morphine has been shown to promote the growth of HIV-1 in vitro (Peterson et al.,1990; Squinto et al.,1990), and promote the growth of SIV in vitro and in vivo in macaques (Chuang et al.,1993). Thus, these drugs may also influence the infectivity of the virus.


Antibody Response Antibody Titer Simian Immunodeficiency Virus Adjuvant Effect Respective Control Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brown, S.M., Stimmel, B., Taub, R.N., Kochwa, S., and Rosenfield, R.E., 1974, Immunologic dysfunction in heroin addicts, Arch. Intern. Med. 134:1001.CrossRefGoogle Scholar
  2. Bussiere, J.L., Adler, M.W., Rogers, T.J., and Eisenstein, T.K., 1993a, Cytokine reversal of morphine-induced suppression of the antibody response, J. Pharmacol. Exp. Ther. 264(2):591–597.Google Scholar
  3. Bussiere, J.L., Taub, D.D., Meissler, J.J. Jr., Adler, M.W., Rogers, T.J., and Eisenstein, T.K., 1993b, Effects of opioids on murine antibody responses, Adv. Biosci. 86:563–572.Google Scholar
  4. Chuang, L.F., Killam, K.F. Jr., and Chuang, R.Y., 1993, Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate, Biochem. Biophys. Res. Comm. 195(3):1165–1173.PubMedCrossRefGoogle Scholar
  5. Haverkos, H.W., 1991, Infectious diseases and drug abuse: prevention and treatment in the drug abuse treatment system, J. Substance Abuse Treat. 8:269–275.CrossRefGoogle Scholar
  6. Haverkos, H.W., and Lange, W.R., 1990, Serious infections other than human immunodeficiency virus among intravenous drug abusers, J. Infect. Dis. 161:894–902.PubMedCrossRefGoogle Scholar
  7. Peterson, P.K., Sharp, B., Gekker, G., Portoghese, P.S., Sannerud, K., and Balfour, H.H.J., 1990, Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures, AIDS 4:869.PubMedCrossRefGoogle Scholar
  8. Squinto, S.P., Mondal, D., Block, A.L., and Prakash, O., 1990, Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells, AIDS Res. Human Retroviruses 6:1163–1167.CrossRefGoogle Scholar
  9. Villacres-Eriksson, M., Bergström-Mollaoglu, M., Kåberg, H., and Morein, B., 1992, Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus 1SCOMS. Scand. J. Immunol. 36:421–426.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Peter A. Virsik
    • 1
  • Jeanine L. Bussiere
    • 1
  1. 1.Department of Pathobiology and Toxicology Genentech Inc.460 Point San Bruno BlvdSouth San FranciscoUSA

Personalised recommendations